Cover Image

Ocular Safety of Intravitreal Injections of Age-Related Macular Degeneration Treatments in a Prospective Observational Cohort Study in Europe

<p><strong>Purpose: </strong>Estimate the incidence of pertinent ocular adverse events (POAEs) related to intravitreal (IVT)injections for age-related macular degeneration (AMD) treatments in Europe.</p><p><strong>Methods: </strong>Ophthalmologists prospecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kui Huang (Author), Marla B. Sultan (Author), Duo Zhou (Author), Charles S. Tressler (Author), Jingping Mo (Author)
Format:	Book
Published:	Journal of Clinical Research and Ophthalmology - Peertechz Publications, 2015-03-23.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intravitreal Bevacizumab Injection Effect in Exudative Age Related Macular Degeneration
by: Gholamhossein Yaghoobi, et al.
Published: (2016)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
by: Laura García-Quintanilla, et al.
Published: (2019)

Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis
by: Ba J, et al.
Published: (2015)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
by: Dominik Zalewski, et al.
Published: (2014)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021)

Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration
by: Shuqian Zhu, et al.
Published: (2023)

Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration
by: Gebran Khneizer, et al.
Published: (2017)

First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration
by: Wissam Aljundi, et al.
Published: (2024)

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
by: Yan PS, et al.
Published: (2016)

First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
by: Alaa Din Abdin, et al.
Published: (2022)

Improvement of Diabetic Macular Edema in the Fellow Eye After Monocular Intravitreal Bevacizumab Injection
by: Hamidreza Torabi
Published: (2017)

Evaluation of Aqueous Flare Intensity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-Related Macular Degeneration
by: Joanna Dolar-Szczasny, et al.
Published: (2021)

Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits
by: Alireza Khodabande, et al.
Published: (2021)

Comparison Of Intravitreal Triamcinolone Injection Vs Laser Photocoagulation in Angiographic Macular Edema in Diabetic Retinopathy
by: Somesh V Aggarwal, et al.
Published: (2012)

Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
by: Wei Q, et al.
Published: (2019)

Accidental intralenticular injection of dexametasone intravitreal implant during the treatment of refractory diabetic macular oedema
by: M. I. Kovtun, et al.
Published: (2018)

A bioengineered anti‐VEGF protein with high affinity and high concentration for intravitreal treatment of wet age‐related macular degeneration
by: Chengnan Huang, et al.
Published: (2024)

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
by: Jose Navarro-Partida, et al.
Published: (2021)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
by: Wataru Kikushima, et al.
Published: (2023)

Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
by: Yunyan Hu, et al.
Published: (2022)

Intravitreal Injection Technique
by: Kasra A. Rezaei, et al.
Published: (2016)

Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab
by: Pablo Almuiña-Varela, et al.
Published: (2024)

Effect of phosphocreatine on ocular hemodynamics and functional status of the macula in patients with dry age-related macular degeneration
by: V.V. Savko Snr, et al.
Published: (2017)

Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
by: Messenger WB, et al.
Published: (2013)

Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
by: Dang Y, et al.
Published: (2014)

Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
by: Stéphanie Baillif, et al.
Published: (2022)

The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
by: Laura García-Quintanilla, et al.
Published: (2024)

The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions
by: Ciloglu E, et al.
Published: (2019)

Nanotechnology for Age-Related Macular Degeneration
by: Bo Yang, et al.
Published: (2021)

Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
by: Wei Q, et al.
Published: (2019)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
by: Tranos P, et al.
Published: (2024)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
by: Lorenzo Ferro Desideri, et al.
Published: (2023)

Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
by: Claudio Bucolo, et al.
Published: (2018)

Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery
by: Tsilimbaris MK, et al.
Published: (2016)

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema
by: Fernando de Andrés-Nogales, et al.
Published: (2018)

Pharmacoeconomic analysis of dexamethasone intravitreal implant for the treatment of diabetic macular edema in Russia
by: A. S. Kolbin, et al.
Published: (2018)

Age-Related Macular Degeneration and Diabetic Retinopathy
Published: (2022)

Global prevalence of age-related macular degeneration
by: Jost B Jonas
Published: (2014)

Mechanism of Inflammation in Age-Related Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2012)

Sterile Endophthalmitis after Intravitreal Injections
by: Joaquín Marticorena, et al.
Published: (2012)